Even low doses of corticosteroids—particularly when used for non-oncologic indications such as autoimmune diseases, chronic obstructive pulmonary disease (COPD), or brain edema—have been associated with inferior outcomes in patients treated with PD-1/PD-L1 inhibitors.20 The gene discussed is CD274; the disease is autoimmune disease.